#Japan #Osaka #Shionogi Healthcare #Influenza Testing #Adtest SARS-CoV-2

Shionogi Healthcare Unveils New OTC Antigen Testing Kit

In a significant move to contribute to public health, Shionogi Healthcare has announced the release of its new over-the-counter (OTC) antigen testing kit, "Adtest® SARS-CoV-2/Flu (for general use)." This innovative product will be available starting November 27. Developed in response to the growing demand for accessible health solutions, this kit is tailored for the detection of COVID-19 and both A and B types of influenza viruses.

Background of the Launch

As society evolves toward a vision where everyone can manage their health proactively, Shionogi Healthcare aims to help individuals easily recognize their health status and pursue timely diagnosis and treatment. The mission behind this product release emphasizes not just healing but also preventive measures to safeguard health.

By introducing this user-friendly testing kit, Shionogi Healthcare aspires to meet the ongoing public health challenges while uplifting the standards of self-care.

Key Features of the Adtest® SARS-CoV-2/Flu Kit

One of the notable features of this testing kit is its rapid results, delivering outcomes in just five minutes. It utilizes a squeeze tube method, eliminating the need for tedious specimen manipulation, thereby reducing the risk of contact contamination and spills. The 'one-touch' design allows for easy insertion of the stick into the tube, facilitating quick and accurate testing procedures.

This kit not only tests for COVID-19 but also simultaneously checks for influenza viruses (both types A and B), making it a versatile tool for those needing fast and efficient diagnostics.

Meeting Consumer Needs

According to consumer surveys, there has been significant demand for testing solutions characterized by speed, simultaneous viral detection, and ease of use. The Adtest kit meets these needs with a design that prioritizes user convenience while assuring reliability and accuracy in results.

Important Usage Information: Users are reminded to follow the instructions provided by pharmacists and to read the guidelines before use. In instances of positive results, it is essential to seek medical advice. Even in cases of negative results, if symptoms persist, medical consultation is advisable.

The kit is classified as a Class 1 pharmaceutical product approved by Japan's Ministry of Health, Labor and Welfare, emphasizing its reliability as a self-diagnostic tool.

Purchase Information

The Adtest® kit is available for purchase through the Shionogi Healthcare online shop.

Shionogi's Commitment to ESG Practices

Shionogi Healthcare is dedicated to fostering an environment where people and society can thrive. Aligning with the United Nations' Sustainable Development Goals (SDGs), the company focuses on health, sustainable city living, gender inequality reduction, economic growth, and environmental stewardship. These initiatives reflect their commitment to addressing social issues through healthcare innovation.

Utilizing Owned Media and Social Networks

To engage the public in effective self-care practices, Shionogi Healthcare actively uses owned media, including their online shop and various social media platforms (X, Instagram, LINE) to provide product information, campaigns, and expert guidance for health management.

Follow Us:

• - Owned Media: Shionogi Healthcare ONLINE
• - Twitter: @shionogi_hc
• - Instagram: @shionogi_hc
• - LINE: @shionogi-hc

About Shionogi Healthcare

Company Name: Shionogi Healthcare Co., Ltd.
Founded: January 15, 2016
Headquarters: Grand Green Osaka, 24F, 5-54 Daifukucho, Kita-ku, Osaka
Business: Development and sale of OTC pharmaceuticals, quasi-drugs, health foods, and various healthcare products.
Contact Information:

• - Osaka TEL: 06-6209-6948
• - Tokyo TEL: 03-3406-8450

Official Site: Shionogi Healthcare

Shionogi Healthcare continues to innovate and evolve the self-care landscape, underscoring their commitment to making self-care accessible and enjoyable for everyone.